Table 1.
Experimental Group (n = 17) | Control Group (n = 21) | p-Value | |||
---|---|---|---|---|---|
Median | IQR | Median | IQR | ||
Age (yr) | 68.0 | (56.5–74.5) | 70.0 | (63.5–74.5) | 0.527 |
Sex (n,%) | 0.444 | ||||
Male | 11 | (64.71%) | 11 | (52.38%) | |
Female | 6 | (35.29%) | 10 | (47.62%) | |
Height (cm) | 158.00 | (155.50–168.25) | 160.00 | (158.10–165.50) | 0.499 |
Weight (kg) | 69.40 | (57.65–70.95) | 72.00 | (60.60–77.30) | 0.122 |
BMI | 24.60 | (21.90–27.35) | 26.70 | (23.56–29.48) | 0.082 |
NIHSS score | 6 | (3–10) | 7 | (4.5–11.5) | 0.594 |
HbA1C (%) | 6.30 | (5.60–7.15) | 6.60 | (6.20–7.55) | 0.181 |
LDL (mg/dL) | 105.00 | (78.00–135.00) | 121.00 | (100.50–179.00) | 0.072 |
Homocysteine (μmol/L) | 11.05 | (7.99–12.52) | 11.00 | (9.50–16.00) | 0.310 |
Stroke type (n,%) | 1.000 | ||||
Hemorrhagic | 5 | (29.41%) | 6 | (28.57%) | |
Ischemic | 12 | (70.59%) | 15 | (71.43%) | |
Stroke site (n,%) | 0.407 | ||||
Left | 6 | (35.29%) | 11 | (52.38%) | |
Right | 10 | (58.82%) | 10 | (47.62%) | |
Bilateral | 1 | (5.88%) | 0 | (0%) | |
Pre-rehabilitation data | |||||
Ext. 60 (N⋅m) | 10.00 | (4.35–20.20) | 10.00 | (8.00–13.50) | 0.755 |
Flex. 60 (N⋅m) | 9.10 | (6.50–10.90) | 11.00 | (8.50–14.50) | 0.095 |
Ext. 120 (N⋅m) | 9.90 | (3.95–14.25) | 12.00 | (9.00–14.50) | 0.176 |
Flex. 120 (N⋅m) | 11.60 | (8.00–15.00) | 15.00 | (10.50–17.50) | 0.066 |
6MWT (m) | 10.00 | (6.00–37.50) | 10.00 | (8.50–12.00) | 0.867 |
TUG (s) | 61.33 | (50.00–115.86) | 57.07 | (41.16–70.29) | 0.107 |
SF-12 | 108.50 | (71.63–114.78) | 106.90 | (100.61–112.24) | 0.685 |
IQR = interquartile range; BMI = body mass index; LDL = low-density lipoprotein; Ext. 60 = extension torque at 60 degrees per second; Flex. 60 = flexion torque at 60 degrees per second; Ext. 120 = extension torque at 120 degrees per second; Flex. 120 = flexion torque at 120 degrees per second; 6 MWT = 6 min walk test; TUG = Timed Up-and-Go test; SF-12 = 12-Item Short Form Survey.